H

Horizon Therapeutics PLC
F:HPR

Watchlist Manager
Horizon Therapeutics PLC
F:HPR
Watchlist
Price: 110.2 EUR Market Closed
Market Cap: 25.3B EUR

Wall Street
Price Targets

HPR Price Targets Summary
Horizon Therapeutics PLC

There are no price targets for HPR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Horizon Therapeutics PLC Competitors:
Price Targets
CRBU
Caribou Biosciences Inc
351% Upside
FYB
Formycon AG
93% Upside
ADCT
ADC Therapeutics SA
168% Upside
FHTX
Foghorn Therapeutics Inc.
95% Upside
DSGN
Design Therapeutics Inc
85% Upside
NBIX
Neurocrine Biosciences Inc
24% Upside
9688
Zai Lab Ltd
36% Upside
BIOCON
Biocon Ltd
1% Upside

Revenue
Forecast

Revenue Estimate
Horizon Therapeutics PLC

For the last 8 years the compound annual growth rate for Horizon Therapeutics PLC's revenue is 37%.

37%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Horizon Therapeutics PLC

Operating Income forecast
is not available for
Horizon Therapeutics PLC

Net Income
Forecast

Net Income Estimate
Horizon Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HPR's stock price target?
Not Available

HPR doesn't have any price targets made by Wall Street professionals.

Back to Top